Caribou Biosciences, Inc. (NASDAQ: CRBU) reported Q1 EPS of ($0.26), $0.07 better than the analyst estimate of ($0.33). Revenue for the quarter came in at $2.39 million versus the consensus estimate of $2.65 million.

For earnings history and earnings-related data on Caribou Biosciences, Inc. (CRBU) click here.